Dealing in Securities by Directors and the Company Secretary of the Company ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or “the Group”) DEALING IN SECURITIES BY DIRECTORS AND THE COMPANY SECRETARY OF THE COMPANY In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information: DIRECTORS OF THE COMPANY Director : Stephen Bradley Saad Date of transaction : 20 October 2020 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 35 173 Class of securities : Ordinary shares Grant price : R108.98 Value of Transaction : R3 833 153.54 Nature of interest : Direct beneficial Clearance obtained : Yes Director : Michael Guy Attridge Date of transaction : 20 October 2020 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 29 077 Class of securities : Ordinary shares Grant price : R108.98 Value of Transaction : R3 168 811.46 Nature of interest : Direct beneficial Clearance obtained : Yes COMPANY SECRETARY OF THE COMPANY Company Secretary : Riaan Verster Date of transaction : 20 October 2020 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 7 341 Class of securities : Ordinary shares Grant price : R108.98 Value of Transaction : R800 022.18 Nature of interest : Direct beneficial Clearance obtained : Yes All acceptances of deferred bonus shares are deemed to be off-market trades. Durban 21 October 2020 Sponsor Investec Bank Limited Date: 21-10-2020 05:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.